SCHEMBL4933877

SCHEMBL4933877

CC(c1nc2ccccc2[nH]1)N1CCCCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 0.53
ACHE P22303 2/20 0.53
MAPT P10636 2/20 0.51
ALDH1A1 P00352 2/20 0.50
POLB P06746 2/20 0.50
IDO1 P14902 1/20 0.50
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
TAAR1 Q96RJ0 1/20 0.49
HTT P42858 1/20 0.49
MLKL Q8NB16 2/20 0.48
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ALOX12 P18054 1/20 0.43
KLK7 P49862 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28722124 0.98 MAPT (0.52) BCHEACHEMAPTALDH1A1POLB
SCHEMBL4929684 0.87 MAPT (0.50) BCHEACHEMAPTALDH1A1POLB
SCHEMBL4933617 0.80 LMNA (0.46) BCHEACHEMAPTALDH1A1POLB
SCHEMBL4155864 0.76 MAPT (0.46) MAPTALDH1A1POLBIDO1TAAR1
SCHEMBL4148419 0.75 OPRM1 (0.50) MAPTALDH1A1POLBIDO1LMNA
SCHEMBL4150713 0.75 OPRL1 (0.50) MAPTALDH1A1POLBIDO1TAAR1
SCHEMBL12737571 0.75 TAAR1 (0.68) ALDH1A1POLBIDO1LMNASMN1; SMN2
SCHEMBL524001 0.75 TAAR1 (0.68) ALDH1A1POLBIDO1LMNASMN1; SMN2
SCHEMBL8330903 0.75 TAAR1 (0.68) ALDH1A1POLBIDO1LMNASMN1; SMN2
SCHEMBL85832 0.75 ALDH1A1 (0.66) ALDH1A1POLBIDO1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080280933-A1 BENZIMIDAZOLYL COMPOUNDS EFREMOV IVAN 2008-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280933-A1 BENZIMIDAZOLYL COMPOUNDS PAICS, TMBIM6, ABCG2 BCHE 233/4885ACHE 450/4885MAPT 2472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.